Advances in Cancer Immunotherapy™

In-depth Education Focused on Your Specialty

The Advances in Cancer Immunotherapy™ (ACI) educational series offers focused clinical education on a disease state or topic. Attendees of these half-day, innovative programs get in-depth training in immunotherapy treatment for a variety of topics from experts in the field. The ACI program also features discussions of closed cases submitted from attendees to hear guidance and insights from faculty. ACI programs are certified for CME, CNE, CPE, and MOC credits.

Browse 2023 ACI Programs

Join SITC In celebrating 10 years of ACI Programming with new topics, new in-person locations, and much more! The 2023 ACI live program series will feature 15 topic-driven programs, approximately 4 hours in length, offering CME, CNE, CPE and MOC credit at no cost for clinicians.

Register now

Featured Courses

Missed a live ACI topic from the last series? You can now watch the recordings for credit, as well as access interactive courses to supplement your knowledge! The online courses listed below are CME-, CPE-, CNE- and MOC-certified supplemental program courses for the ACI education series. Participation by clinicians is strongly recommended, however the courses are available to anyone.

Immunotherapy

Introduction to Immunotherapy

This interactive course provides an overview of the immune system, focusing on the mechanisms by which the immune system eliminates foreign pathogens and cancer cells.

Learn More >
Immunotherapy

Basic Principles of Cancer Immunotherapy

Learn the biological foundations of immunotherapy, types of immunotherapies, illustrate how biomarkers play a major role in immunotherapy.

Learn More >
Immunotherapy

A Focus on Skin Cancer

Learn to identify the cancer immunotherapy approaches in use for the treatment of skin cancers and implement cancer immunotherapy for skin cancer into clinical practice appropriately.

Learn More >
Immunotherapy

A Focus on Intratumoral Therapies, Vaccines, and Cytokines

Learn to describe the mechanisms of intratumoral therapies, vaccines, and cytokines.

Learn More >
Immunotherapy


View All Courses

Browse our entire selection of online courses.



View Courses >
Register

Registration Info

View registration rates, policies, & more. SITC members receive a discount, and courses are free for healthcare professionals in the clinical setting, students and patient advocates.

View Details

ACI Online

Online ACI Courses

As a component of the SITC in-person ACI programs, SITC is pleased to offer free online, introductory, CME-, CPE-, CNE- and/or MOC-certified programs.

Register

Enduring materials

Enduring Materials

View slide decks, videos, and other course materials from prior ACI programs. SITC members have access to our entire resource library.

Access Materials

About

Program Purpose

Designed by SITC, the ACI programs are introductory, CME-, CNE-, CPE- and MOC-certified programs, presented by leading authorities in tumor and cancer immunotherapy.

Learn More

Registration Information

Members of the Society for Immunotherapy of Cancer (SITC) are eligible for discounted registration rates. To receive discounted member rates, your membership dues must be current. Renew your dues or apply for membership.

Please note your registration classification to determine the correct registration rate. For non-members, your classification is determined by your primary institution.

ACIs are free for healthcare professionals in the clinical setting, students and patient advocates.

Registration Rates >

Rates per Program

SITC Member Rates Non-Member Rates
*Student, Patient, Caregiver Free Free
Non-Industry Nurse or Pharmacist, Patient Advocate, Foundation/Non-Profit, Patient Advocacy Organization Free Free
Clinician, Academic Free Free
Government, Non-Industry Free Free
Industry (Includes Industry Nurses and Pharmacists) $300.00 $370.00
Investor $300.00 $370.00

Cancellation / Refund Policy >

All cancellations must be received in writing. You may fax your cancellation to +1 414-276-3349 or e-mail events@sitcancer.org. Requests must be made 3 weeks prior to the event. A $25 processing fee will be charged for all paid registration cancellations.

All refunds will be processed after the programs; you will receive an e-mail confirmation. No refunds will be granted if cancellation is received after the 3 weeks out date . Special considerations will be given for health or family emergencies if requested in writing to events@sitcancer.org no later than 14 business days after the last day of the programs.

Photography Policy and Meeting Code of Conduct >

SITC often employs the services of a professional photographer/videographer at SITC events to capture images and audiovisual (AV) recordings for use in society archival and promotional material. Your attendance at SITC events implies your permission for images and an AV recording captured to be used for purposes of SITC archival materials, promotional materials, and publications, and waives your rights for compensation or ownership of these images.

View the SITC Meeting Code of Conduct.

Webinars and Online Modules

SITC is pleased to offer free online, introductory, CME-, CPE-, CNE- and/or MOC-certified programs via the society's online learning portal, SITC Cancer Immunotherapy connectED. These online activities provide an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy. If you missed the opportunity to attend an Advances in Cancer Immunotherapy™ event, you can still obtain the education and CME, CPE, CNE and/or MOC credits through many of the online programs listed here. Important to note, if you received credit for attending a live ACI, you cannot receive credit for the same online ACI course (e.g. you attended the ACI: A Focus on Lung Cancer live webinar, you could not also receive credit for the on-demand ACI: A Focus on Lung Cancer).

Click on each activity title to view full accreditation information and the types of credits offered for each program. 

Learn more about online ACI courses >

Complete these certified, interactive online courses to deepen your understanding of cancer immunotherapy and learn about the most recent FDA approvals in several diseases states and the latest guidelines on how to treat immune-related adverse events. Additional courses address how to overcome practical barriers to implementation, which are critical for helping your staff to help patients obtain reimbursement for immunotherapy. Each course is eligible for CME, CNE, CPE and/or MOC credits.

Online courses include links to the original trials, the latest FDA approvals, real-world case studies and questions to help deepen understanding and retention. There are also printable charts outlining best practices for treating immune-related adverse effects and links to the Cancer Immunotherapy Guidelines which can support decision-making.

ACI Webinars >

Log in to the free ACI webinars to learn about new treatment approvals and emerging scientific data relating to clinical applications of cancer immunotherapy. Hosted by experts in the field, the webinars provide an opportunity to continue your learning from this ACI program and interact with faculty during a dedicated question-and-answer session.

On-Demand Webinar Recordings and Slides

Please note that the on-demand webinars are not available for continuing education credits.

Enduring Materials

Links will be added as materials become available. Not a SITC member? Materials are available for purchase for 90 days after the program date. Program materials for the 2017-18, 2018-19 and 2019-20 Advances in Cancer ImmunotherapyTM programs are available in the SITC Resource Library

2021-2022 ACI PROGRAMS >

2020-2021 ACI PROGRAMS >

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC), the Advances in Cancer Immunotherapy™ (ACI) programs are CME-, CNE-, CPE- and MOC-certified programs, presented by leading authorities in tumor immunology and cancer immunotherapy. SITC has partnered with the Association of Community Cancer Centers (ACCC), the Advanced Practitioner Society for Hematology and Oncology (APSHO), the American Academy of Emergency Medicine (AAEM), the Hematology/Oncology Pharmacists Association (HOPA) to provide a comprehensive program providing critical information to incorporate immunotherapy into clinical practice. Each program will present the latest updates in the specific field addressed by the program, giving a deep dive into practical application, immune-related adverse events, and future trends.

Program Highlights >

  • Overview of common approaches to cancer immunotherapy and their related mechanisms
  • Timely updates on the latest clinical advances in the field, including data from recent scientific meetings and clinical trials
  • Dedicated opportunities for clinicians to ask questions and receive direction on difficult cases
  • Strategies for addressing the practical barriers to implementing immunotherapy (operations, reimbursement and management of emerging toxicities)

Intended Audience >

The ACI programs aim to reach practicing clinical oncologists, advanced practitioners, nurses, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Planning Committee

The Society for Immunotherapy of Cancer (SITC) is extremely grateful for the support of the following members of the Planning Committee for the Advances in Cancer Immunotherapy™ educational series.

2023 ACI Planning Committee >

  • Sanjiv S. Agarwala, MD
    Temple University
  • Christian Capitini, MD (Chair)
    University of Wisconsin Carbone Cancer Center
  • Amber Cipriani, PharmD, BCOP, CPP
    UNC Healthcare
  • Marianne Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP (Co-chair
    Yale School of Nursing
  • Adi Diab, MD
    The University of Texas MD Anderson Cancer Center
  • Isabella C. Glitza, MD, PhD
    The University of Texas MD Anderson Cancer Center
  • Paul S. Jansson, MD, MS
    Harvard Medical School
  • Lisa Kottschade, APRN, MSN, CNP
    Mayo Clinic
  • Zihai Li, MD, PhD
    The Ohio State University
  • Pradnya Patil, MD, FACP
    Cleveland Clinic Taussig Cancer Center
  • Chrystal Paulos, PhD
    Emory University
  • Mark Rubinstein, PhD
    Cleveland Clinic Taussig Cancer Center
  • Raju Vaddepally, MD
    Yuma Regional Medical Center Cancer Center
  • Yiping Yang, MD, PhD
    The Ohio State University
  • Dan P. Zandberg, MD
    UPMC Hillman Cancer Center
  • Lei Zheng, MD, PhD
    Johns Hopkins University School of Medicine

2021-2022 ACI Planning Committee >

  • Sanjiv S. Agarwala, MD (Chair)
    Temple University
  • Christian Capitini, MD (Co-chair)
    University of Wisconsin Carbone Cancer Center
  • Amber Cipriani, PharmD, BCOP, CPP
    UNC Healthcare
  • Marianne Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP
    Yale School of Nursing
  • Adi Diab, MD
    The University of Texas MD Anderson Cancer Center
  • Sarah B. Dubbs, MD, FAAEM
    University of Maryland School of Medicine
  • Isabella C. Glitza, MD, PhD
    The University of Texas MD Anderson Cancer Center
  • Zihai Li, MD, PhD
    The Ohio State University
  • Pradnya Patil, MD, FACP
    Cleveland Clinic Taussig Cancer Center
  • Chrystal Paulos, PhD
    Emory University
  • Mark Rubinstein, PhD
    Cleveland Clinic Taussig Cancer Center
  • Yiping Yang, MD, PhD
    The Ohio State University
  • Dan P. Zandberg, MD
    UPMC Hillman Cancer Center
  • Lei Zheng, MD, PhD
    Johns Hopkins University School of Medicine

Technology Policy and Information

For optimal completion of this program, the attendee will need a computer/laptop with a strong WiFi connection and the ability to stream video.

Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

View the SITC Meeting Code of Conduct.